TIGIT and neoplasm: In recent years, it has been shown that tissue-resident T lymphocytes can overexpress PD-1 and other immune checkpoint molecules, such as TIGIT, LAG-3, and Tim-3, in some experimental animal and human tumor tissues (36, 48).